<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="peptide 1. Alzheimer’s Epidemiology Alzheimer’s disease (AD) is a progressive" exact="neurological disorder" post="that accounts for the greatest number of dementia cases."/>
 <result pre="progressive neurological disorder that accounts for the greatest number of" exact="dementia" post="cases. As of 2019, 5.8 million people were living"/>
 <result pre="appears to be more responsible for subsequent cognitive impairment and" exact="dementia" post="symptoms associated with AD [8]. Indeed, tau hyperphosphorylation and"/>
 <result pre="clinical studies, with one study seeing 6% of participants develop" exact="meningoencephalitis" post="[21,22]. Tarenflurbil, for instance, had been administered clinically, after"/>
 <result pre="the latter have been shown to be able to detect" exact="neurodegeneration" post="in presymptomatic AD [36]. Other highly sensitive methods that"/>
 <result pre="in AD brains [45,46,47,48,49,50]. This notion draws parallels with the" exact="measles" post="virus, which can lead to the development of the"/>
 <result pre="lead to the development of the neurological disease known as" exact="subacute sclerosing panencephalitis" post="[51]. These findings include the identification of viral [52]"/>
 <result pre="samples [68]. Interestingly, fungal infection from species primarily associated with" exact="periodontal disease" post="has recently been suggested to be involved in AD"/>
 <result pre="having a role in innate immunity as an AMP that" exact="aids" post="in the entrapment and degradation of invading bacteria and"/>
 <result pre="they has been associated with the development of plaques in" exact="atherosclerosis" post="and other non-infectious diseases [98]. Protein analyses comparing known"/>
 <result pre="shown to have antiviral activity against both HSV-1 and the" exact="influenza" post="virus A by inhibiting the infectivity of HSV-1 [82],"/>
 <result pre="influenza virus A by inhibiting the infectivity of HSV-1 [82]," exact="influenza" post="virus A [103], H3N2 [103] and H1N1 [103]. Researchers"/>
 <result pre="object learning, verbal memory and working memory in patients with" exact="schizophrenia" post="[115]. Due to its effects on working memory, its"/>
 <result pre="enzyme BBB blood brain barrier CNS central nervous system HSV-1" exact="herpes simplex" post="virus-1 MBP-1 major basic protein-1 NFTS neurofibrillary tangles References"/>
 <result pre="miceNeuron20054719119910.1016/j.neuron.2005.06.03016039562 20.KimJ.OnsteadL.RandleS.PriceR.SmithsonL.ZwizinskiC.DicksonD.W.GoldeT.McGowanE.Abeta40 inhibits amyloid deposition in vivoJ. Neurosci.20072762763310.1523/JNEUROSCI.4849-06.200717234594 21.OrgogozoJ.M.GilmanS.DartiguesJ.F.LaurentB.PuelM.KirbyL.C.JouannyP.DuboisB.EisnerL.FlitmanS.et al.Subacute" exact="meningoencephalitis" post="in a subset of patients with AD after Abeta42"/>
 <result pre="of an Infectious Etiology of Alzheimer DiseaseMol. Neurobiol.2019564479449110.1007/s12035-018-1388-y30338482 51.MurphyJ.V.YunisE.J.Encephalopathy following" exact="measles" post="infection in children with chronic illnessJ. Pediatrics19768893794210.1016/S0022-3476(76)81045-1 52.DobsonC.B.ItzhakiR.F.Herpes simplex"/>
 <result pre="of Alzheimer’s Disease DevelopmentJ. Alzheimer’s Dis.20186193994510.3233/JAD-16130529254081 56.LinardM.LetenneurL.GarrigueI.DoizeA.DartiguesJ.F.HelmerC.Interaction between APOE4 and" exact="herpes simplex" post="virus type 1 in Alzheimer’s diseaseAlzheimer’s Dement. J. Alzheimer’s"/>
 <result pre="in Alzheimer’s diseaseAlzheimer’s Dement. J. Alzheimer’s Assoc.20201620020810.1002/alz.12008 57.De ChiaraG.PiacentiniR.FabianiM.MastrodonatoA.MarcocciM.E.LimongiD.NapoletaniG.ProttoV.ColuccioP.CelestinoI.et al.Recurrent" exact="herpes simplex" post="virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits"/>
 <result pre="57.De ChiaraG.PiacentiniR.FabianiM.MastrodonatoA.MarcocciM.E.LimongiD.NapoletaniG.ProttoV.ColuccioP.CelestinoI.et al.Recurrent herpes simplex virus-1 infection induces hallmarks of" exact="neurodegeneration" post="and cognitive deficits in micePLoS Pathog.201915e100761710.1371/journal.ppat.100761730870531 58.WozniakM.A.ShipleyS.J.CombrinckM.WilcockG.K.ItzhakiR.F.Productive herpes simplex"/>
 <result pre="hallmarks of neurodegeneration and cognitive deficits in micePLoS Pathog.201915e100761710.1371/journal.ppat.100761730870531 58.WozniakM.A.ShipleyS.J.CombrinckM.WilcockG.K.ItzhakiR.F.Productive" exact="herpes simplex" post="virus in brain of elderly normal subjects and Alzheimer’s"/>
 <result pre="elderly normal subjects and Alzheimer’s disease patientsJ. Med. Virol.20057530030610.1002/jmv.2027115602731 59.JamiesonG.A.MaitlandN.J.WilcockG.K.CraskeJ.ItzhakiR.F.Latent" exact="herpes simplex" post="virus type 1 in normal and Alzheimer’s disease brainsJ."/>
 <result pre="Cell Culture ModelJ. Alzheimer’s Dis.2016501227124110.3233/JAD-15065226836158 83.De ChiaraG.MarcocciM.E.CivitelliL.ArgnaniR.PiacentiniR.RipoliC.ManservigiR.GrassiC.GaraciE.PalamaraA.T.APP processing induced by" exact="herpes simplex" post="virus type 1 (HSV-1) yields several APP fragments in"/>
 <result pre="compartments and the inhibition of the non-amyloidogenic pathway in human" exact="neuroblastoma" post="cellsNeurobiol. Aging201233430.e19430.e3310.1016/j.neurobiolaging.2010.12.01021272962 85.Li PumaD.D.PiacentiniR.LeoneL.GironiK.MarcocciM.E.De ChiaraG.PalamaraA.T.GrassiC.Herpes Simplex Virus Type-1 Infection"/>
 <result pre="accumulationSci. Rep.201551544410.1038/srep1544426487282 87.KristenH.SantanaS.SastreI.RecueroM.BullidoM.J.AldudoJ.Herpes simplex virus type 2 infection induces AD-like" exact="neurodegeneration" post="markers in human neuroblastoma cellsNeurobiol. Aging2015362737274710.1016/j.neurobiolaging.2015.06.01426163986 88.MiklossyJ.KisA.RadenovicA.MillerL.ForroL.MartinsR.ReissK.DarbinianN.DarekarP.MihalyL.et al.Beta-amyloid deposition"/>
 <result pre="virus type 2 infection induces AD-like neurodegeneration markers in human" exact="neuroblastoma" post="cellsNeurobiol. Aging2015362737274710.1016/j.neurobiolaging.2015.06.01426163986 88.MiklossyJ.KisA.RadenovicA.MillerL.ForroL.MartinsR.ReissK.DarbinianN.DarekarP.MihalyL.et al.Beta-amyloid deposition and Alzheimer’s type changes"/>
 <result pre="92.KhanM.B.LangM.J.HuangM.B.RaymondA.BondV.C.ShiramizuB.PowellM.D.Nef exosomes isolated from the plasma of individuals with HIV-associated" exact="dementia" post="(HAD) can induce Aβ(1-42) secretion in SH-SY5Y neural cellsJ."/>
 <result pre="95.BurgosJ.S.RamirezC.SastreI.BullidoM.J.ValdiviesoF.ApoE4 is more efficient than E3 in brain access by" exact="herpes simplex" post="virus type 1Neuroreport2003141825182710.1097/00001756-200310060-0001314534428 96.WozniakM.A.MeeA.P.ItzhakiR.F.Herpes simplex virus type 1 DNA"/>
 <result pre="upregulated in Alzheimer’s brainJ. Neuroinflamm.20131012710.1186/1742-2094-10-127 103.WhiteM.R.KandelR.TripathiS.CondonD.QiL.TaubenbergerJ.HartshornK.L.Alzheimer’s associated β-amyloid protein inhibits" exact="influenza" post="A virus and modulates viral interactions with phagocytesPLoS ONE20149e10136410.1371/journal.pone.010136424988208"/>
 <result pre="key Alzheimer’s disease molecules in cell cultures acutely infected with" exact="herpes simplex" post="virus type 1PLoS ONE20116e2515210.1371/journal.pone.002515222003387 113.ZambranoA.SolisL.SalvadoresN.CortesM.LerchundiR.OtthC.Neuronal cytoskeletal dynamic modification and"/>
 <result pre="simplex virus type 1PLoS ONE20116e2515210.1371/journal.pone.002515222003387 113.ZambranoA.SolisL.SalvadoresN.CortesM.LerchundiR.OtthC.Neuronal cytoskeletal dynamic modification and" exact="neurodegeneration" post="induced by infection with herpes simplex virus type 1J."/>
 <result pre="113.ZambranoA.SolisL.SalvadoresN.CortesM.LerchundiR.OtthC.Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with" exact="herpes simplex" post="virus type 1J. Alzheimer’s Dis.20081425926910.3233/JAD-2008-1430118599953 114.HuiZ.ZhijunY.YushanY.LipingC.YiyingZ.DifanZ.ChunglitC.T.WeiC.The combination of acyclovir"/>
 <result pre="inhibitor BAY 57-1293 reduces the Alzheimer’s disease-related molecules induced by" exact="herpes simplex" post="virus type 1Antivir. Res.20139940140410.1016/j.antiviral.2013.07.00323867133 118.BaumeisterJ.FischerR.EckenbergP.HenningerK.Ruebsamen-WaigmannH.KleymannG.Superior efficacy of helicase-primase inhibitor"/>
 <result pre="diseaseAntivir. Chem. Chemother.200718354810.1177/09563202070180010417354650 119.BetzU.A.FischerR.KleymannG.HendrixM.Rubsamen-WaigmannH.Potent in vivo antiviral activity of the" exact="herpes simplex" post="virus primase-helicase inhibitor BAY 57-1293Antimicrob. Agents Chemother.2002461766177210.1128/AAC.46.6.1766-1772.200212019088 120.KleymannG.Helicase primase:"/>
 <result pre="57-1293Antimicrob. Agents Chemother.2002461766177210.1128/AAC.46.6.1766-1772.200212019088 120.KleymannG.Helicase primase: Targeting the Achilles heel of" exact="herpes simplex" post="virusesAntivir. Chem. Chemother.20041513514010.1177/09563202040150030315266895 121.KleymannG.FischerR.BetzU.A.HendrixM.BenderW.SchneiderU.HandkeG.EckenbergP.HewlettG.PevznerV.et al.New helicase-primase inhibitors as drug"/>
 <result pre="al.New helicase-primase inhibitors as drug candidates for the treatment of" exact="herpes simplex" post="diseaseNat. Med.2002839239810.1038/nm0402-39211927946 122.HayashiK.HayashiT.MoritaN.Mechanism of action of the antiherpesvirus biflavone"/>
</results>
